These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Discovery and characterization of endogenous cannabinoids. Martin BR; Mechoulam R; Razdan RK Life Sci; 1999; 65(6-7):573-95. PubMed ID: 10462059 [TBL] [Abstract][Full Text] [Related]
24. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Felder CC; Briley EM; Axelrod J; Simpson JT; Mackie K; Devane WA Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7656-60. PubMed ID: 8395053 [TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationships of anandamide, an endogenous cannabinoid ligand. Khanolkar AD; Makriyannis A Life Sci; 1999; 65(6-7):607-16. PubMed ID: 10462061 [TBL] [Abstract][Full Text] [Related]
26. The endocannabinoid system: physiology and pharmacology. RodrÃguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444 [TBL] [Abstract][Full Text] [Related]
27. The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic? Lambert DM; Di Marzo V Curr Med Chem; 1999 Aug; 6(8):757-73. PubMed ID: 10469890 [TBL] [Abstract][Full Text] [Related]
29. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630 [TBL] [Abstract][Full Text] [Related]
30. Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments. Di Marzo V; De Petrocellis L; Bisogno T; Melck D Lipids; 1999; 34 Suppl():S319-25. PubMed ID: 10419192 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular effects of cannabinoids. Randall MD; Harris D; Kendall DA; Ralevic V Pharmacol Ther; 2002 Aug; 95(2):191-202. PubMed ID: 12182966 [TBL] [Abstract][Full Text] [Related]
32. Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development? Fowler CJ; Jacobsson SO Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):193-200. PubMed ID: 12052035 [TBL] [Abstract][Full Text] [Related]
34. Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration. Basavarajappa BS; Nixon RA; Arancio O Mini Rev Med Chem; 2009 Apr; 9(4):448-62. PubMed ID: 19356123 [TBL] [Abstract][Full Text] [Related]
35. The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease. Navarro M; RodrÃguez de Fonseca F Neurobiol Dis; 1998 Dec; 5(6 Pt B):379-85. PubMed ID: 9974172 [No Abstract] [Full Text] [Related]
36. Anandamide--a new look on fatty acid ethanolamides. Berdyshev EV; Boichot E; Lagente V J Lipid Mediat Cell Signal; 1996 Dec; 15(1):49-67. PubMed ID: 9029374 [No Abstract] [Full Text] [Related]
37. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Skaper SD; Buriani A; Dal Toso R; Petrelli L; Romanello S; Facci L; Leon A Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3984-9. PubMed ID: 8633002 [TBL] [Abstract][Full Text] [Related]
38. N-arachidonoylethanolamine (anandamide), an endogenous cannabinoid receptor ligand, and related lipid molecules in the nervous tissues. Sugiura T; Kondo S; Sukagawa A; Tonegawa T; Nakane S; Yamashita A; Waku K J Lipid Mediat Cell Signal; 1996 Sep; 14(1-3):51-6. PubMed ID: 8906545 [TBL] [Abstract][Full Text] [Related]